Stockscreener 앱 받기
4.03
12.01%
-0.55
시장 영업 전:
3.74
-0.29
-7.20%
전일 마감가:
$4.58
열려 있는:
$3.89
하루 거래량:
813.87K
Relative Volume:
28.71
시가총액:
$3.03M
수익:
-
순이익/손실:
$-4.14M
주가수익비율:
-0.5558
EPS:
-7.2511
순현금흐름:
$-4.79M
1주 성능:
-35.00%
1개월 성능:
-23.68%
6개월 성능:
-28.57%
1년 성능:
-44.95%
1일 변동 폭
$3.5601
$4.103
1주일 범위
$3.5601
$6.1999
52주 변동 폭
$3.42
$25.50
Bone Biologics Corp Stock (BBLG) Company Profile
명칭
Bone Biologics Corp
전화
(781) 552-4452
주소
2 BURLINGTON WOODS DRIVE,, BURLINGTON
BBLG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
4.03 | 3.03M | 0 | -4.14M | -4.79M | -7.2511 |
|
ABT
Abbott Laboratories
|
136.01 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
107.41 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.63 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.17 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.21 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Bone Biologics Corp 주식(BBLG)의 최신 뉴스
Bone Morphogenetic Protein Market Expected to Hit USD 12.3 Billion by 2032 with a Remarkable 5.03% CAGR - industrytoday.co.uk
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Update - Defense World
Bone Biologics (OTC:BBLG) Trading Down 11.7% – Should You Sell? - Defense World
United States shares higher at close of trade; Dow Jones Industrial Average up 0.25% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.25% - Investing.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.25% - Investing.com UK
Bone Biologics (BBLG) Trading Halt Sparks Anticipation | BBLG St - GuruFocus
Bone Biologics announces 1-for-6 reverse stock split By Investing.com - Investing.com South Africa
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split | BB - GuruFocus
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split - GuruFocus
Bone Biologics announces 1-for-6 reverse stock split - Investing.com
Bone Biologics (BBLG) Announces 1-for-6 Reverse Stock Split | BBLG Stock News - GuruFocus
Bone Biologics Announces 1-for-6 Reverse Stock Split - Business Wire
Bone Biologics (NASDAQ:BBLG) Trading Down 2.4% – What’s Next? - Defense World
Bone Biologics shareholders approve key proposals By Investing.com - Investing.com Canada
Bone Biologics shareholders approve key proposals - Investing.com
Global and China Osteoporosis Drugs Market Detailed in New Research ReportAmgen, Eli Lilly - openPR.com
Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews
Bone Biologics (OTC:BBLG) Shares Up 18.5% – Time to Buy? - Defense World
TETROUS®, INC. ANNOUNCES EXPANDED CLINICAL APPLICATIONS OF ENFIX® FOR ENTHESIS REPAIR - Longview News-Journal
(BBLGW) Proactive Strategies - news.stocktradersdaily.com
WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering - Barchart.com
Zacks Small Cap Forecasts Bone Biologics Q2 Earnings - Defense World
Bone Biologics Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Trend Tracker for (BBLGW) - news.stocktradersdaily.com
Orthobiologics Market Grows Strong with Expanding Use in Sports - openPR.com
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics - IT News Online
Revolutionary BMP Super-Agonists: Darnatein's New Biologics Promise Breakthrough in Bone and Cartilage Repair - Stock Titan
Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe - Yahoo Finance
Bone Biologics (OTC:BBLG) Trading Down 0.4% – Should You Sell? - Defense World
BBLG stock touches 52-week low at $0.57 amid market challenges By Investing.com - Investing.com South Africa
BBLG stock touches 52-week low at $0.57 amid market challenges - Investing.com Australia
Orthobiologics Market Set to Witness Significant Growth - openPR.com
Aurobindo Pharma Arm Completes Phase 1 Trials of New Bone Medicine - Equitypandit
When (BBLGW) Moves Investors should Listen - news.stocktradersdaily.com
BBLG stock touches 52-week low at $0.7 amid market challenges - Investing.com Canada
BBLG stock touches 52-week low at $0.7 amid market challenges By Investing.com - Investing.com South Africa
Bone Biologics (OTC:BBLG) Trading 1.9% Higher – Here’s What Happened - Defense World
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Bone Biologics sets date for 2025 annual meeting - Investing.com
Top Trend In Orthobiologics Devices And Equipment Market 2025: Biodegradable Implants Transforming Orthobio... - WhaTech
Orthobiologics Market Future Business Opportunities - openPR.com
TETROUS®, INC. SIGNS NEW DISTRIBUTION AGREEMENT IN NEW ZEALAND TO EXPAND PRESENCE IN THE ASIA-PACIFIC MARKET AND ADDS DR. CRAIG BALL TO IT'S SURGEON ADVISORY BOARD - PR Newswire
Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors - The Malaysian Reserve
Bone Biologics (OTC:BBLG) Trading 1.2% Higher – Here’s Why - Defense World
MTF Biologics Collaborates with Kolosis BIO to Boost DBX Brand - World Business Outlook
MTF Biologics Expands Partnership with Kolosis BIO to Strengthen DBX Brand - StreetInsider.com
TETROUS®, INC. SUCCESSFULLY CLOSES FINANCING ROUND, SECURING ADDITIONAL CAPITAL FOR FUTURE GROWTH - PR Newswire
Bone Biologics Corp (BBLG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.35%
0.66%
자본화:
|
볼륨(24시간):